Oryzon Genomics, S.A. (MAD: ORY) ("Oryzon" or the "Company"), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical needs, today ...
Read moreAt today’s virtual Annual General Shareholders’ Meeting, shareholders granted discharge to the Executive Board and the Supervisory Board and approved the boards’ proposals by a large majority. T...
Read moreOrigo Biopharma has announced the closing of a €2,3 million Series Seed financing, with the participation from Sabadell Asabys, XesGalicia and the founding shareholders. The financing, led ...
Read moreDeepUll announced today the closing of a 3.5 million Euro round Series A financing led by Alta Life Sciences and Kurma Partners and with participation from Axis Participaciones Empresariales and Sofim...
Read moreThe oversubscribed round was co-led by Ysios Capital and INKEF Capital; Lundbeckfonden Ventures and LSP joined the syndicate. Founding investor, BioGeneration Ventures (BGV) and the regional economic ...
Read moreLa compañía biotecnológica Archivel Farma ha creado una nueva compañía,Immuni Therapeutics, para desarrollar la vacuna RUTI® como una vacuna eficaz contra infecciones víricas (incluyendo COVID-...
Read moreTelum Therapeutics (‘Telum’), an emerging biotechnology company that develops new treatments for infectious diseases based on the use of lytic enzymes from bacteriophages, called enzybiotics, has ...
Read moreThe Josep Carreras Leukaemia Research Institute, a public centre pertaining to the Generalitat de Catalunya's (Government of Catalonia) CERCA network, has created the OneChain Immunotherapeutics (OCI)...
Read moreEs un profesional con dilatada experiencia en el sector financiero y se une a 3P para impulsar el crecimiento de la compañía
Read moreNEOS Surgery, a company that researches, develops and markets implantable surgical devices for brain, spinal and cardiothoracic surgeries, has closed a €5-million funding operation, with Avançsa an...
Read moreLa compañía biotecnológica Algenex ha cerrado una ronda de financiación privada por valor de 7,4 millones de euros liderada por MasterLux, inversor asesorado por Cleon Capital y Vita Advisory. Est...
Read moreLAVA Therapeutics, a biotech company pioneering the development of bispecific antibodies to engage gamma-delta T cells for cancer therapies, today announced the closing of an oversubscribed $83 millio...
Read more